We are very sorry but it looks like you are using an outdated browser. We strongly recommend updating to a modern browser.
More information about your browser and how to update

Exosome Diagnostics GmbH

Exosome Diagnostics is a young company in rapid growth. The company's headquarters and main R&D facilities are on Manhattan, New York, US and additional sites are located in Minnesota, US and Munich, Germany. Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine, and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technology makes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases. The Company is commercializing in vitro diagnostic tests for use in companion diagnostic applications and real-time monitoring of disease.

Details


Address:
Exosome Diagnostics GmbH

Am Klopferspitz 19a
IZB Martinsried
82152 Martinsried
Germany
Field of Activity:
Clinical Research
Hospital & Medical Practice
Other Activities
Research & Development
Expansion:
international
Number of employess:
11-50
Founding year:
2008